Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
92.57
+1.48 (1.62%)
At close: Dec 20, 2024, 4:00 PM
92.15
-0.42 (-0.45%)
After-hours: Dec 20, 2024, 6:57 PM EST
Gilead Sciences Stock Forecast
Stock Price Forecast
The 24 analysts with 12-month price forecasts for Gilead Sciences stock have an average target of 96.71, with a low estimate of 69 and a high estimate of 125. The average target predicts an increase of 4.47% from the current stock price of 92.57.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for GILD stock from 26 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 2 | 2 | 3 |
| Buy | 3 | 3 | 4 | 8 | 10 | 11 |
| Hold | 11 | 11 | 11 | 10 | 12 | 12 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 17 | 20 | 24 | 26 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $80 | Hold | Reiterates | $80 | -13.58% | Dec 11, 2024 |
| RBC Capital | RBC Capital | Hold Reiterates $84 | Hold | Reiterates | $84 | -9.26% | Dec 11, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $105 → $115 | Buy | Reiterates | $105 → $115 | +24.23% | Dec 10, 2024 |
| B of A Securities | B of A Securities | Strong Buy Initiates $109 | Strong Buy | Initiates | $109 | +17.75% | Dec 10, 2024 |
| UBS | UBS | Hold Maintains $70 → $96 | Hold | Maintains | $70 → $96 | +3.71% | Nov 21, 2024 |
Financial Forecast
Revenue This Year
28.88B
from 27.12B
Increased by 6.50%
Revenue Next Year
28.98B
from 28.88B
Increased by 0.36%
EPS This Year
4.50
from 4.50
Increased by 0.02%
EPS Next Year
7.69
from 4.50
Increased by 70.96%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 30.1B | 31.1B | 33.0B | |||
| Avg | 28.9B | 29.0B | 29.8B | |||
| Low | 27.5B | 26.5B | 27.4B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 11.0% | 7.8% | 13.7% | |||
| Avg | 6.5% | 0.4% | 2.9% | |||
| Low | 1.2% | -8.2% | -5.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 4.94 | 8.81 | 9.14 | |||
| Avg | 4.50 | 7.69 | 8.06 | |||
| Low | 4.21 | 6.25 | 6.39 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 9.7% | 95.7% | 18.7% | |||
| Avg | 0.0% | 71.0% | 4.7% | |||
| Low | -6.4% | 38.9% | -17.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.